Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
MEDIUM RISK
Score updated Aug 28, 2026

INBX — Inhibrx Biosciences, Inc. Dilution Risk Tracker

Track INBX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INBX — Get alerts when the score changes →

As of August 28, 2026, Inhibrx Biosciences, Inc. (INBX) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. Inhibrx Biosciences, Inc. has a market capitalization of $1.53B, 14.72M shares outstanding, 140 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
40
📊 Float Risk
60
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for INBX.
🔔 Track INBX — Get forecast alerts →

Market Data

Market Cap$1.53B
Shares Outstanding14.72M
Float7.86M
Cash$133.34M
Debt$176.28M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.8% shares (2026Q1 vs prior)
140 institutional holders · 17.29M shares
#1 PERCEPTIVE ADVISORS LLC 2.89M shares
#2 MORGAN STANLEY 2.87M shares
#3 VIKING GLOBAL INVESTORS LP 1.44M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.34M
Days to Cover15.6
% of Float42.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
8-K PDUFA EVENT 2026-06-15
Full SEC filing analysis available with free account

Recent News

No recent news

Factual INBX Dilution Snapshot

Inhibrx Biosciences, Inc. (INBX) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track INBX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INBX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INBX
INBX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.